Market News How it works Learn FAQ
| DVLT 0.0879 31.19% | RCT 0.0617 -5.95% | CDT 0.083 3.75% | NVD 4.01 2.04% | STLA 4.68 13.04% | BBD 2.73 -6.19% | SPCX 145.23 -2.25% | NVDA 215.38 -1.17% | EWZ 33.62 -1.98% | NU 11.97 -3.51% | SOXL 107.35 6.20% | GPUS 0.1908 -10.25% | SOFI 17.14 4.51% | GERN 0.9685 -15.78% | INTC 95.53 1.91% | ORCL 144.34 10.58% | NOK 9.22 3.71% | CHSN 1.46 35.19% | SOXS 39.78 -6.39% | BSX 42.43 -5.84% | AAL 12.58 -0.24% | SHFS 0.094 -18.83% | HYG 77.59 -0.01% | RWM 14.27 -0.49% | CRWV 63.93 7.32% | SPDN 8.41 -0.36% | QID 13.69 -1.23% | BRAI 3.6 8.76% | IREN 28.84 5.10% | TQQQ 72.36 1.86% | T 20.72 -1.05% | KPTI 0.8321 73.35% | GRAB 2.75 1.10% | CIFR 8.87 4.60% | HODO 0.046 -15.13% | VALE 11.47 -3.13% | F 11.93 1.88% | TSLG 5.72 -1.72% | WULF 13.42 6.00% | SKHY 164.7 13.30% | CCC 7.67 -0.39% | WFF 0.053 -11.81% | TSLL 11.45 -1.55% | KORU 13.78 16.19% | ONCO 0.5979 25.98% | ONDS 6.86 3.16% | PLUG 1.42 1.43% | BITO 10.88 0.83% | NFLX 61.99 -0.85% | POM 1.8 29.50%
STStarling Oncology, Inc. logo

Starling Oncology, Inc. (STLN)

NASDAQ · Currency in USD
$6.64 ▲ +0.05 (+0.76%)
At close: Oct 28, 4:00 PM ET. Market closed.
$6.70 ▲ +0.06 (+0.90%)
After hours: Oct 28, 6:12 PM ET

Summary

Previous Close
$6.59
Open
$6.62
Day's Range
$6.50 – $6.79
52 Week Range
$2.32 – $7.13
Volume
1,143,439
Avg. Volume
1,514,758
Market Cap
$663.89M
Beta (5Y Monthly)
0.42
PE Ratio (TTM)
--
EPS (TTM)
-$0.35
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$9.00

Profile: Starling Oncology, Inc.

Sector
Healthcare
Industry
Medical - Care Facilities
Full-time employees
641
CEO
Daniel Virnich

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.

Earnings

DateEst.Actual
Aug 6, 2026-$0.06-$0.08Miss
May 7, 2026-$0.09-$0.02Beat
Aug 13, 2025-$0.12-$0.15Miss
May 14, 2025–-$0.21
Aug 13, 2024-$0.09-$0.17Miss

Analyst view

Consensus price target
$9.00 ▲ +35.5%
Range $9.00 – $9.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on STLN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.